Sean M. Hickey

EMRA Critical Care Committee Vice Chair, 2019-2020

Residency: Mount Sinai School of Medicine
Medical school: Albert Einstein College of Medicine

A complex trial meant to determine whether hydrocortisone can improve outcomes for patients with severe COVID-19 was stopped early - but still shows promise for the course.
With no clear consensus on the use of steroids in critically ill sepsis patients, a recent meta-analysis studies the 28-day mortality in critically ill COVID-19 patients when corticosteroids are admin
This study sheds more light on how the administration of ascorbic acid, corticosteroids, and thiamine might affect the rates of organ injury in patients suffering septic shock. The takeaway? It's not
Intubating the critically ill septic patient is a high-risk procedure. We examine an observational study that reported higher levels of procedural hypotension with the use of ketamine when compared to
As much of the U.S. experiences a resurgence of COVID-19 cases heading into the height of summer, research continues at a brisk pace. Can dexamethasone - a relatively inexpensive, commonly prescribed
The Adaptive COVID-19 Treatment Trial (ACTT), while controversial, is the first major trial to suggest benefit from remdesivir for hospitalized COVID-19 patients. Unfortunately, study results don't sh
In the quest to conquer sepsis, a new randomized controlled trial has tested hydrocortisone, vitamin C, and thiamine as a treatment.
The first RCT studying the use of dexamethasone in ARDS shows promise for the emergency medicine setting.
Can prophylactic antibiotics affect the incidence of ventilator-associated pneumonia following out-of-hospital cardiac arrest?
CHAT NOW
CHAT OFFLINE